Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol
Molecular Weight | 692.7 g/mol |
---|---|
Molecular Formula | C27H48O20 |
XLogP3 | -7.5 |
Hydrogen Bond Donor Count | 11 |
Hydrogen Bond Acceptor Count | 20 |
Rotatable Bond Count | 12 |
Exact Mass | 692.27389392 g/mol |
Monoisotopic Mass | 692.27389392 g/mol |
Topological Polar Surface Area | 306 Ų |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Complexity | 950 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 20 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20879
Submission : 2007-09-21
Status : Active
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6031
Submission : 1985-08-29
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7074
Submission : 1987-06-30
Status : Inactive
Type : II
Certificate Number : R1-CEP 2010-242 - Rev 00
Issue Date : 2017-06-29
Type : Chemical
Substance Number : 1785
Status : Valid
Certificate Number : R1-CEP 2010-284 - Rev 00
Issue Date : 2017-06-29
Type : Chemical
Substance Number : 1785
Status : Valid
Certificate Number : R1-CEP 2014-281 - Rev 00
Issue Date : 2020-03-26
Type : Chemical
Substance Number : 1785
Status : Valid
Certificate Number : R1-CEP 2013-234 - Rev 00
Issue Date : 2019-06-21
Type : Chemical
Substance Number : 1785
Status : Valid
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Armenia
Clotrimazole; Zinc Oxide; Cornstarch; Talc API
Brand Name :
Dosage Form : Powder
Dosage Strength : 1GM; 10GM; 10GM; 79GM
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Armenia
https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination
Market Place
Reply
16 Jun 2022
Reply
17 Aug 2018
Reply
12 Apr 2022
Reply
28 Oct 2021
Reply
11 Jan 2019
Reply
18 Aug 2018
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
43
PharmaCompass offers a list of Cornstarch API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cornstarch manufacturer or Cornstarch supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cornstarch manufacturer or Cornstarch supplier.
PharmaCompass also assists you with knowing the Cornstarch API Price utilized in the formulation of products. Cornstarch API Price is not always fixed or binding as the Cornstarch Price is obtained through a variety of data sources. The Cornstarch Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sta-RX 1500 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sta-RX 1500, including repackagers and relabelers. The FDA regulates Sta-RX 1500 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sta-RX 1500 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sta-RX 1500 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sta-RX 1500 supplier is an individual or a company that provides Sta-RX 1500 active pharmaceutical ingredient (API) or Sta-RX 1500 finished formulations upon request. The Sta-RX 1500 suppliers may include Sta-RX 1500 API manufacturers, exporters, distributors and traders.
click here to find a list of Sta-RX 1500 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sta-RX 1500 DMF (Drug Master File) is a document detailing the whole manufacturing process of Sta-RX 1500 active pharmaceutical ingredient (API) in detail. Different forms of Sta-RX 1500 DMFs exist exist since differing nations have different regulations, such as Sta-RX 1500 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sta-RX 1500 DMF submitted to regulatory agencies in the US is known as a USDMF. Sta-RX 1500 USDMF includes data on Sta-RX 1500's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sta-RX 1500 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sta-RX 1500 suppliers with USDMF on PharmaCompass.
A Sta-RX 1500 CEP of the European Pharmacopoeia monograph is often referred to as a Sta-RX 1500 Certificate of Suitability (COS). The purpose of a Sta-RX 1500 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sta-RX 1500 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sta-RX 1500 to their clients by showing that a Sta-RX 1500 CEP has been issued for it. The manufacturer submits a Sta-RX 1500 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sta-RX 1500 CEP holder for the record. Additionally, the data presented in the Sta-RX 1500 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sta-RX 1500 DMF.
A Sta-RX 1500 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sta-RX 1500 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sta-RX 1500 suppliers with CEP (COS) on PharmaCompass.
Sta-RX 1500 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sta-RX 1500 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sta-RX 1500 GMP manufacturer or Sta-RX 1500 GMP API supplier for your needs.
A Sta-RX 1500 CoA (Certificate of Analysis) is a formal document that attests to Sta-RX 1500's compliance with Sta-RX 1500 specifications and serves as a tool for batch-level quality control.
Sta-RX 1500 CoA mostly includes findings from lab analyses of a specific batch. For each Sta-RX 1500 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sta-RX 1500 may be tested according to a variety of international standards, such as European Pharmacopoeia (Sta-RX 1500 EP), Sta-RX 1500 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sta-RX 1500 USP).